Use este identificador para citar ou linkar para este item: http://www.repositorio.ufop.br/jspui/handle/123456789/7864
Registro completo de metadados
Campo Dublin CoreValorIdioma
dc.contributor.authorAlzamora, Andréia Carvalho-
dc.contributor.authorSantos, Robson Augusto Souza dos-
dc.contributor.authorSantos, Maria José Campagnole dos-
dc.date.accessioned2017-06-02T16:55:43Z-
dc.date.available2017-06-02T16:55:43Z-
dc.date.issued2002-
dc.identifier.citationALZAMORA, A. C.; SANTOS, R. A. S.; SANTOS, M. J. C. Hypotensive effect of Ang II and Ang-(1-7) at the caudal ventrolateral medulla involves different mechanisms. Regulatory, Integrative and Comparative Physiology, v. 283, p. R1187-R1195, 2002. Disponível em: <http://ajpregu.physiology.org/content/283/5/R1187>. Acesso em: 19 fev. 2017.pt_BR
dc.identifier.issn1522-1490-
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/7864-
dc.description.abstractHypotensive effect of ANG II and ANG-(1–7) at the caudal ventrolateral medulla involves different mechanisms. Am J Physiol Regul Integr Comp Physiol 283: R1187–R1195, 2002. First published July 18, 2002; 10.1152/ ajpregu.00580.2001.—The objective of the present study was to determine the contribution of the autonomic nervous system and nitric oxide to the depressor effect produced by unilateral microinjection of ANG-(1–7) and ANG II into the caudal ventrolateral medulla (CVLM). Unilateral microinjection of ANG-(1–7), ANG II (40 pmol), or saline (100 nl) was made into the CVLM of male Wistar rats anesthetized with urethane before and after intravenous injection of 1) methylatropine, 2.5 mg/kg; 2) prazosin, 25 g/kg; 3) the nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), 5 mg/kg; or 4) the specific inhibitor of neuronal NOS, 7-nitroindazole (7-NI), 45 mg/kg. Arterial pressure and heart rate (HR) were continuously monitored. Microinjection of ANG-(1–7) or ANG II into the CVLM produced a significant decrease in mean arterial pressure (MAP; 11 1 mmHg, n 12 and 10 1 mmHg, n 10, respectively) that was not accompanied by consistent changes in HR or in cardiac output. The effect of ANG-(1–7) was abolished after treatment with methyl-atropine ( 3 0.6 mmHg, n 9) or L-NAME ( 2.3 0.5 mmHg, n 8) or 7-NI ( 2.8 0.6 mmHg, n 5). In contrast, these treatments did not significantly interfere with the ANG II effect ( 10 2.6 mmHg, n 8; 8 1.5 mmHg, n 8; and 12 3.6 mmHg, n 6; respectively). Peripheral treatment with prazosin abolished the hypotensive effect of ANG-(1–7) and ANG II. Microinjection of saline did not produce any significant change in MAP or in HR. These results suggest that the hypotensive effect produced by ANG II at the CVLM depends on changes in adrenergic vascular tonus and, more importantly, the hypotensive effect produced by ANG-(1–7) also involves a nitric oxide-related mechanism.pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectAngiotensinpt_BR
dc.subjectArterial pressurept_BR
dc.subjectNitric oxidept_BR
dc.subjectSympathetic nervous systempt_BR
dc.titleHypotensive effect of Ang II and Ang-(1-7) at the caudal ventrolateral medulla involves different mechanisms.pt_BR
dc.typeArtigo publicado em periodicopt_BR
dc.identifier.uri2http://ajpregu.physiology.org/content/283/5/R1187pt_BR
dc.identifier.doihttps://doi.org/10.1152/ajpregu.00580.2001-
Aparece nas coleções:DECBI - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_HypotensiveEffectANGII.pdf
  Restricted Access
170,37 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.